Results 261 to 270 of about 14,082,843 (400)
High-Sensitivity cardiac troponin I in the diagnosis of acute myocardial infarction: A study in patients with renal insufficiency. [PDF]
Li Z +11 more
europepmc +1 more source
Abstract Background and Purpose Mavacamten (MAVA) is a novel small molecule inhibitor of cardiac myosin, mitigating cardiomyocyte hypercontractility in patients with hypertrophic obstructive cardiomyopathy (HOCM). Despite its recent approval for clinical use, the transcriptional and functional impacts of MAVA remain not well understood.
Elisa Kiselev +36 more
wiley +1 more source
Correction: Research progress on nanomaterial-empowered electrochemical biosensors for the detection of cardiac troponin I. [PDF]
Zhang N +7 more
europepmc +1 more source
An internal regulatory element controls troponin I gene expression.
Katherine E. Yutzey +2 more
openalex +2 more sources
Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction–relaxation cycle in isolated cardiac myofibrils [PDF]
Martina Krüger +7 more
openalex +1 more source
Abstract Background and Purpose Plasma glucocorticoids increase acutely after MI, thereafter tissue levels are amplified selectively within cells expressing 11‐ßhydroxysteroid dehydrogenase type 1 (11‐ßHSD1) that regenerates active glucocorticoids from circulating metabolites.
Sara Al Disi +19 more
wiley +1 more source
Early prediction of sepsis-induced cardiorenal syndrome: superiority of myoglobin over troponin I. [PDF]
Liu Y +5 more
europepmc +1 more source
PHGDH promoted cardiomyocyte proliferation and myocardial regeneration via cell cycle and TGF‐β/Smad signalling pathways during cardiac repair. Moreover, PHGDH benefits cardiac repair and cardiomyocyte proliferation in mammalian mice following MI. ABSTRACT The mature mammalian heart has limited ability for self‐repair and regeneration.
Han Zhang +6 more
wiley +1 more source

